Neal Walker, Director at Aclaris Therapeutics, Inc. (ACRS), sold 63,382 shares at $14.89 ($960K) on 2023-01-04, disclosed to the SEC on 2023-01-04.
Open-market sale of $960k ACRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.19 | 23,382 | $355K | 37.0% |
| 2 | $15.19 | 23,382 | $355K | 37.0% |
| 3 | $16.16 | 1,618 | $26K | 2.7% |
| 4 | $14.89 | 15,000 | $223K | 23.3% |
| Total | $15.14 avg | 63,382 | $960K | 100% |
| Filing → |
| ACRS | SELL | 2022-04-25 | $1.1M | — | Filing → |
| ACRS | SELL | 2022-03-14 | $1.8M | — | Filing → |
| ACRS | SELL | 2022-02-11 | $46K | — | Filing → |